Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: Potassium binders in clinical practice: understanding potassium binder use in contemporary Swedish healthcare—the DEMONSTRATE database

Fig. 1

Overlapping comorbidities for patients who were treated with (A) first- or (B) second-generation potassium binders. The analysis was performed separately for patients included in the National Cohort and patients included in the Mid-Sweden Cohort. Four comorbidities, including heart failure (HF), diabetes mellitus (DM), hypertension (HYP), and chronic kidney disease (CKD), were included in the analysis

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us